GENOME KEY
GenomeKey is an award-winning, early-phase company that is exploiting innovative genomic technology and cutting-edge AI machine learning to address critical healthcare challenges.
GENOME KEY
Industry:
Artificial Intelligence Bioinformatics Health Care Machine Learning
Founded:
2020-12-05
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.genomekey.co
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
3.6 M USD
Current Employees Featured
Founder
More informations about "Genome Key"
Transformative Diagnostics - IVD device | GenomeKey
See transformative diagnostics. GenomeKey’s IVD device empowers clinicians to treat infections like sepsis with the right antibiotics fasterSee details»
GenomeKey - Crunchbase Company Profile & Funding
GenomeKey is an award-winning, early-phase company that is exploiting innovative genomic technology.See details»
GenomeKey - LinkedIn
About GenomeKey GenomeKey is a biotechnology company developing a 7-hour, whole genome sequencing diagnostic solutions for infectious disease.See details»
GenomeKey - Leadership Team | The Org
The Leadership Team at GenomeKey steers the company's strategic vision and direction, spearheading efforts to integrate cutting-edge genomic technology into innovative solutions. …See details»
GenomeKey - Crustdata Company Profile, Funding and Growth
GenomeKey is an award-winning, early-phase company that is exploiting innovative genomic technology and cutting-edge AI machine learning to address critical healthcare challenges. …See details»
Transformative diagnostics | GenomeKey
We’re working to create transformative diagnostics. We are developing innovative technology to make global impact – find out more.See details»
GenomeKey awarded $11.4M to transform sepsis diagnosis and …
Aug 1, 2024 GenomeKey has been awarded a major grant from Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) to build a functioning, automated prototype …See details»
Genome Key - Crunchbase Company Profile & Funding
GenomeKey is an award-winning, early-phase company that is exploiting innovative genomic technology and cutting-edge AI machine learning to address critical healthcare challenges.See details»
GenomeKey: Novel blood diagnostic for rapid bacterial pathogen ...
GenomeKey is building a world where nobody dies from a treatable infection. We are transforming diagnostics with our next-generation IVD device, which maps the right antibiotic to the right …See details»
GenomeKey on LinkedIn: #nextgenerationsequencing …
We are GenomeKey, a team of scientists, engineers, clinicians, commercial diagnostic professionals and entrepreneurs who want to create a new standard of…See details»
Meet the team - GenomeKey
Our team are dedicated to creating the best bacterial diagnostic device to support clinicians to identify the right antibiotics, faster.See details»
GenomeKey on LinkedIn: Join Michael Roberts, our CEO, as he …
Join Michael Roberts, our CEO, as he discusses GenomeKey's journey and reveals key strategies for scaling a biotechnology startup. Don't miss his talk at the…See details»
GenomeKey - Funding, Financials, Valuation & Investors
GenomeKey is an award-winning, early-phase company that is exploiting innovative genomic technology.See details»
GenomeKey awarded US$11.4M from global non-profit CARB-X
GenomeKey is developing a next-generation in vitro diagnostic device that’s set to become the new standard for bacterial identification. The device will be able to detect and identify bacteria …See details»
Partnerships in Diagnostics | GenomeKey
Discover how our range of partnerships enables us to provide transformative diagnostics to rapidly treat infections like sepsis.See details»
GenomeKey on LinkedIn: Continuing our Employee Spotlight …
Continuing our Employee Spotlight series, we would like to introduce Dr Clio Andreae, our Senior Scientist and Quality Representative, based in Bristol at Science Creates. Clio has a …See details»
The TyphiNET data visualisation dashboard: unlocking
May 9, 2025 For example, the World Health Organization (WHO) ‘AWaRe (Access, Watch, Reserve) Antibiotic Book’ [12] recommends treating suspected typhoid with ciprofloxacin if the …See details»
GenomeKey on LinkedIn: CEO and founder of GenomeKey Dr …
CEO and founder of GenomeKey Dr Michael Roberts and CSO Dr Dan Rogerson in conversation about frontier science, machine learning and the new standard of bloodborne bacterial …See details»
Machine learning identification of enhancers in the rhesus …
1 day ago He et al. demonstrate a “monkey-first” approach to cell-type-specific reagent development. They use machine learning to identify enhancers from rhesus monkey …See details»
GenomeKey - Contacts, Employees, Board Members, Advisors
GenomeKey is an award-winning, early-phase company that is exploiting innovative genomic technology.See details»